Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort

Published on Dec 1, 2019in European Archives of Psychiatry and Clinical Neuroscience3.288
· DOI :10.1007/S00406-018-0908-0
Guillaume Fond27
Estimated H-index: 27
,
Ophélia Godin27
Estimated H-index: 27
+ 24 AuthorsMarion Leboyer120
Estimated H-index: 120
(French Institute of Health and Medical Research)
Sources
Abstract
A high rate of patients with schizophrenia (SZ) does not sufficiently respond to antipsychotic medication, which is associated with relapses and poor outcomes. Chronic peripheral inflammation has been repeatedly associated with schizophrenia risk and particularly to poor responders to treatment as usual with cognitive impairment in SZ subjects. The objective of present study was to confirm if ultra resistance to treatment in schizophrenia (UTRS) was associated to chronic peripheral inflammation in a non-selected sample of community-dwelling outpatients with schizophrenia. Participants were consecutively included in the network of the FondaMental Expert Centers for Schizophrenia and received a thorough clinical assessment, including recording of current treatment. Current psychotic symptomatology was evaluated by the Positive and Negative Syndrome scale for Schizophrenia (PANSS). UTRS was defined by current clozapine treatment + PANSS total score ≥ 70. Functioning was evaluated by the Global Assessment of Functioning scale. High sensitivity CRP (hs-CRP) was measured for each participant as a proxy to define peripheral low-grade inflammation. 609 stabilized community-dwelling SZ subjects (mean age = 32.5 years, 73.6% male gender) have been included. 60 (9.9%) patients were classified in the UTRS group. In multivariate analyses, UTRS has been associated independently with chronic peripheral inflammation (OR = 2.6 [1.2–5.7], p = 0.01), illness duration (0R = 1.1 [1.0–1.2], p = 0.02) and impaired functioning (OR = 0.9 [0.9–0.9], p = 0.0002) after adjustment for age, sex, current daily tobacco smoking, metabolic syndrome and antidepressant consumption. Peripheral low-grade inflammation is associated with UTRS. Future studies should explore if anti-inflammatory strategies are effective in UTRS with chronic low-grade peripheral inflammation.
📖 Papers frequently viewed together
13 Citations
21 Citations
References49
Newest
#1Henriette Thisted Horsdal (Lundbeck)H-Index: 14
#2Theresa Wimberley (Lundbeck)H-Index: 15
Last. Christiane Gasse (Lundbeck)H-Index: 28
view all 4 authors...
OBJECTIVE: Schizophrenia is associated with increased levels of inflammatory markers. However, it remains unclear whether inflammatory markers are associated with treatment-resistant schizophrenia. METHODS: We conducted a population-based follow-up study among individuals with a first-time schizophrenia diagnosis and a baseline C-reactive protein measurement (a commonly available marker of systemic inflammation) from 2000 to 2012. We defined treatment resistance as the earliest observed instance...
6 CitationsSource
#1Sabina Abidi (Dal: Dalhousie University)H-Index: 11
#2Irfan Mian (U of T: University of Toronto)H-Index: 6
Last. D. Addington (Centre for Mental Health)H-Index: 5
view all 9 authors...
Objective:Schizophrenia spectrum and other psychotic disorders often have their onset in adolescence. The sequelae of these illnesses can negatively alter the trajectory of emotional, cognitive, and social development in children and youth if left untreated. Early and appropriate interventions can improve outcomes. This article aims to identify best practices in the pharmacotherapy management of children and youth with schizophrenia spectrum disorders.Methods:A systematic search was conducted fo...
19 CitationsSource
#1Ryan S. Sultan (Columbia University)H-Index: 5
#2Mark Olfson (Columbia University)H-Index: 121
Last. Erica Duncan (Emory University)H-Index: 30
view all 4 authors...
BACKGROUND: Concerns exist that clozapine is underutilized in the management of treatment-resistant schizophrenia. Although a 2015 change in the US Food and Drug Administration (FDA) monitoring recommendations lowered the threshold of the absolute neutrophil count for treatment interruption from 1,500/μL to 1,000/μL and removed white blood cell count thresholds from the monitoring algorithm, the implications of this policy change on clozapine interruptions remain unknown. METHODS: We analyzed ou...
20 CitationsSource
#1Gary Remington (U of T: University of Toronto)H-Index: 83
#2Donald Addington (U of C: University of Calgary)H-Index: 60
Last. Michael D. Teehan (Dal: Dalhousie University)H-Index: 9
view all 6 authors...
Objective:The present guidelines address the pharmacotherapy of schizophrenia in adults across different stages, phases, and symptom domains.Method:Guidelines were developed using the ADAPTE process, which takes advantage of existing guidelines. Six guidelines were identified for adaptation, with recommendations extracted from each. For those specific to the pharmacotherapy of schizophrenia in adults, a working group selected between guidelines and recommendations to create an adapted guideline....
88 CitationsSource
#1Dan Siskind (UQ: University of Queensland)H-Index: 31
#2Victor Siskind (QUT: Queensland University of Technology)H-Index: 53
Last. Steve Kisely (UQ: University of Queensland)H-Index: 42
view all 3 authors...
Clozapine is the most effective antipsychotic for the 25% to 33% of people with schizophrenia who are treatment resistant, but not all people achieve response. Using data from a previously published clozapine systematic review and meta-analysis, we explored the proportion of people who achieved response and examined the absolute and percentage change in Positive and Negative Syndrome Scale (PANSS) scores. Overall, 40.1% (95% confidence interval [CI], 36.8%-43.4%) responded, with a mean reduction...
109 CitationsSource
#1Shohei Nishimon (Juntendo University)H-Index: 5
#2Tohru Ohnuma (Juntendo University)H-Index: 25
Last. Heii Arai (Juntendo University)H-Index: 52
view all 15 authors...
Abstract Inflammation may be involved in the pathophysiology of schizophrenia. However, few cross-sectional or longitudinal studies have examined changes in biomarker expression to evaluate diagnostic and prognostic efficacy in acute-stage schizophrenia. We compared serum inflammatory biomarker concentrations in 87 patients with acute-stage schizophrenia on admission to 105 age-, sex-, and body mass index (BMI)-matched healthy controls. The measured biomarkers were soluble tumor necrosis factor ...
9 CitationsSource
2 CitationsSource
#1Oliver D. Howes (U of T: University of Toronto)H-Index: 79
#2Robert McCutcheon (U of T: University of Toronto)H-Index: 20
Last. Christoph U. Correll (U of T: University of Toronto)H-Index: 109
view all 51 authors...
Objective:Research and clinical translation in schizophrenia is limited by inconsistent definitions of treatment resistance and response. To address this issue, the authors evaluated current approaches and then developed consensus criteria and guidelines.Method:A systematic review of randomized antipsychotic clinical trials in treatment-resistant schizophrenia was performed, and definitions of treatment resistance were extracted. Subsequently, consensus operationalized criteria were developed th...
342 CitationsSource
#1Bruno Bertolucci Ortiz (UNIFESP: Federal University of São Paulo)H-Index: 8
Last. Ary Gadelha (UNIFESP: Federal University of São Paulo)H-Index: 29
view all 10 authors...
Abstract Few studies have examined the progression of symptom dimensions in schizophrenia patients over the course of the illness. The objective of this study was to investigate whether clinical and psychopathological differences exist between first-episode schizophrenia (FES) and multiple-episode patients in an inpatient setting. Patients (N = 203) were evaluated using the Positive and Negative Syndrome Scale (PANSS) over time. Five different generalized estimating equations were built for the ...
11 CitationsSource
#1Dolores KeatingH-Index: 3
#2Stephen McWilliamsH-Index: 11
Last. Mary Clarke (BlackRock)H-Index: 42
view all 7 authors...
Objectives Clinical practice guidelines (CPGs) support the translation of research evidence into clinical practice. Key health questions in CPGs ensure that recommendations will be applicable to the clinical context in which the guideline is used. The objectives of this study were to identify CPGs for the pharmacological treatment of first-episode schizophrenia; assess the quality of these guidelines using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument; and comp...
58 CitationsSource
Cited By22
Newest
#1Marco Spangaro (UniSR: Vita-Salute San Raffaele University)H-Index: 14
Last. Roberto Cavallaro (UniSR: Vita-Salute San Raffaele University)H-Index: 30
view all 9 authors...
Abstract null null Treatment-resistant schizophrenia (TRS) represents a main clinical issue, associated with worse functional outcome and higher healthcare costs. Clozapine is the most effective antipsychotic for TRS, although 40% of resistant patients, defined as ultra-treatment resistant (UTR), are clozapine-refractory. Previous literature suggests that TRS is characterized by worse cognitive functioning and a more disrupted neurobiological substrate, but only few studies focused on UTR schizo...
Source
#1Hervé JavelotH-Index: 10
#2Clara Gitahy Falcão Faria (UFRJ: Federal University of Rio de Janeiro)H-Index: 2
view all 0 authors...
Although clinical pharmacy is a discipline that emerged in the 1960s, the question of precisely how pharmacists can play a role in therapeutic optimization remains unanswered. In the field of mental health, psychiatric pharmacists are increasingly involved in medication reconciliation and therapeutic patient education (or psychoeducation) to improve medication management and enhance medication adherence, respectively. However, psychiatric pharmacists must now assume a growing role in team-based ...
Source
#1Matej ĽuptákH-Index: 1
#2Danica Michaličková (First Faculty of Medicine, Charles University in Prague)H-Index: 5
Last. Jana HroudováH-Index: 19
view all 5 authors...
1 CitationsSource
Abstract Background Peripheral inflammation is associated with impaired prognosis in schizophrenia (SZ). Highly sensitive C-reactive protein (hs-CRP) is the most used inflammatory biomarker in daily practice. However, no consensual cut-off has been determined to date to discriminate patients with peripheral inflammation from those without. Aims To determine if patients with peripheral inflammation between 1 and 3 mg/L had poorer outcomes compared to those with undetectable CRP ( Method Consecuti...
1 CitationsSource
#1Flurin Cathomas (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 11
#2Federica Klaus (UCSD: University of California, San Diego)H-Index: 5
Last. Philippe N. Tobler (UZH: University of Zurich)H-Index: 40
view all 11 authors...
One aspect of goal-directed behavior, which is known to be impaired in patients with schizophrenia (SZ), is balancing between exploiting a familiar choice with known reward value and exploring a lesser known, but potentially more rewarding option. Despite its relevance to several symptom domains of SZ, this has received little attention in SZ research. In addition, while there is increasing evidence that SZ is associated with chronic low-grade inflammation, few studies have investigated how this...
5 CitationsSource
#1Guillaume FondH-Index: 27
#2Mélanie FaugereH-Index: 10
Last. C. LançonH-Index: 19
view all 9 authors...
BACKGROUND While psychotic remission in schizophrenia (SZ) has been defined by consensus and associated with a rank of clinical predictive factors, there is a lack of data of factors associated with functional remission. OBJECTIVES To identify clinical and biological factors associated with impaired functional remission in a non-selected chronic stabilized SZ outpatients. METHODS This study was a cross-sectional study carried out on all admitted SZ stabilized outpatients in an academic daily car...
2 CitationsSource
Source
#1Maria MaślińskaH-Index: 9
Last. Marek KrzystanekH-Index: 11
view all 3 authors...
Source
#1Célia KowalH-Index: 2
#2Hugo PeyreH-Index: 20
Last. Baptiste PignonH-Index: 11
view all 7 authors...
OBJECTIVE Several studies have shown that psychiatric disorders can be associated with venous thromboembolism (VTE) risk, that is, pulmonary embolism (PE) and/or deep vein thrombosis (DVT). In this study, we provide a systematic review and meta-analyses of the studies addressing this issue. METHODS All studies addressing the risk of VTE phenomena (whole VTE, PE, DVT, fatal VTE) in individuals with psychotic, mood, and anxiety disorders published between 1998 and 2019 were reviewed and included i...
2 CitationsSource
The intestinal epithelial layer serves as a physical and functional barrier between the microbe-rich lumen and immunologically active submucosa; it prevents systemic translocation of microbial pyrogenic products (e.g. endotoxin) that elicits immune activation upon translocation to the systemic circulation. Loss of barrier function has been associated with chronic 'low-grade' systemic inflammation which underlies pathogenesis of numerous no-communicable chronic inflammatory disease. Thus, targeti...
8 CitationsSource